- $2.51bn
- $3.22bn
- $1.89bn
Brief: Quaker Houghton Announces Quarterly Dividend And $250 Million Stock Repurchase Authorization
Quaker Chemical beats Q1 sales estimates on new business wins
Brief: Quaker Chemical Q1 Adjusted EPS USD 1.63 Vs. IBES Estimate USD 1.63
U.S. RESEARCH ROUNDUP-Elevance Health, Huntington Bancshares, Monolithic Power Systems
Brief: Quaker Houghton Announces Amended Credit Agreement Extends Debt Maturities And Increases Available Credit
U.S. RESEARCH ROUNDUP-EQT, Las Vegas Sands, Twilio
Quaker Chemical's Q4 adjusted profit misses estimates after organic sales dip
Brief: Quaker Chemical Q4 Adjusted EPS USD 1.65 Vs. IBES Estimate USD 1.77
U.S. RESEARCH ROUNDUP-Datadog, IBM, Netflix
Quaker Chemical beats Q3 sales, adjusted profit estimates
Brief: Quaker Chemical Q3 Adjusted EPS USD 2.08 Vs. IBES Estimate USD 2.05
Brief: Quaker Houghton Announces Leadership Appointments
U.S. RESEARCH ROUNDUP-Mongdob, Quaker Houghton, Regeneron Pharmaceuticals
Quaker Chemical Corp reports results for the quarter ended June 30 - Earnings Summary
Quaker Chemical Q2 sales beat estimates
Brief: Quaker Houghton Announces A 5% Increase In Cash Dividend
U.S. RESEARCH ROUNDUP- Intuitive Surgical, Oracle, Regeneron Pharmaceuticals
Quaker Chemical Corp reports results for the quarter ended March 31 - Earnings Summary
Brief: Quaker Chemical Q1 Adjusted EPS USD 1.58 Vs. IBES Estimate USD 1.57